{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:59:38Z","timestamp":1790078378209,"version":"4.0.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/inf.0b013e318234c886","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T03:49:17Z","timestamp":1320292157000},"page":"1069-1074","source":"Crossref","is-referenced-by-count":12,"title":["Point-of-care Capillary Blood Lactate Measurements in Human Immunodeficiency Virus\u2013uninfected Children With In Utero Exposure to Human Immunodeficiency Virus and Antiretroviral Medications"],"prefix":"10.1097","volume":"30","author":[{"given":"Marilyn J.","family":"Crain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Griner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Tassiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Mofenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/0036554021000026992","article-title":". Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.","volume":"35","author":"Huynh","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R2-12-20210202","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/00002030-200207050-00005","article-title":". Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.","volume":"16","author":"Moyle","year":"2002","journal-title":"AIDS"},{"issue":"suppl 2","key":"R3-12-20210202","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1086\/367565","article-title":"Lactic acidemia in infection with human immunodeficiency virus.","volume":"36","author":"Carr","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R4-12-20210202","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00126334-200408010-00007","article-title":". Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.","volume":"36","author":"Lonergan","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-12-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jinf.2006.01.003","article-title":". Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART.","volume":"54","author":"Haugaard","year":"2007","journal-title":"J Infect"},{"key":"R6-12-20210202","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/QAD.0b013e3282f08cdc","article-title":"Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.","volume":"21","year":"2007","journal-title":"AIDS"},{"issue":"suppl 1","key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00126334-200309011-00013","article-title":". Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.","volume":"34","author":"Montaner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.inf.0000086400.93257.74","article-title":". Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.","volume":"22","author":"Alimenti","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00002030-200105250-00023","article-title":". Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.","volume":"15","author":"Giaquinto","year":"2001","journal-title":"AIDS"},{"key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/01.inf.0000083826.11124.b1","article-title":". Hyperlactatemia in human immunodeficiency virus-uninfected children receiving antiretroviral treatment.","volume":"22","author":"Noguera","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1542\/peds.2006-0371","article-title":". Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hepatites Virales 1209 study, Abidjan, Ivory Coast.","volume":"118","author":"Ekouevi","year":"2006","journal-title":"Pediatrics"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/em.20279","article-title":". Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues.","volume":"48","author":"Benhammou","year":"2007","journal-title":"Environ Mol Mutagen"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s001340050558","article-title":". Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment.","volume":"24","author":"Scalfaro","year":"1998","journal-title":"Intensive Care Med"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":". Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"R15-12-20210202","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1542\/peds.2007-0391","article-title":". Mitochondrial disease: a practical approach for primary care physicians.","volume":"120","author":"Haas","year":"2007","journal-title":"Pediatrics"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jemermed.2007.11.099","article-title":". Point-of-care testing at triage decreases time to lactate level in septic patients.","volume":"38","author":"Goyal","year":"2010","journal-title":"J Emerg Med"},{"key":"R17-12-20210202","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.clinbiochem.2008.08.088","article-title":". Comparison and validation of point of care lactate meters as a replacement for fetal pH measurement.","volume":"41","author":"Ridenour","year":"2008","journal-title":"Clin Biochem"},{"key":"R18-12-20210202","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10545-005-0090-1","article-title":". Clinical evaluation of a portable lactate meter in type I glycogen storage disease.","volume":"28","author":"Saunders","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"R19-12-20210202","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.327.7417.711","article-title":". Drug points: fatal lactic acidosis associated with tenofovir.","volume":"327","author":"Rivas","year":"2003","journal-title":"BMJ"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/QAI.0b013e31817e6391","article-title":". Validation of a portable hand-held lactate analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda.","volume":"49","author":"Kiragga","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-12-20210202","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijid.2008.03.007","article-title":". Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting.","volume":"12","author":"Perez","year":"2008","journal-title":"Int J Infect Dis"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.aids.0000216382.37679.b2","article-title":"Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings.","volume":"20","author":"Ivers","year":"2006","journal-title":"AIDS"},{"key":"R23-12-20210202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.281.2.151","article-title":". Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219076 Teams.","volume":"281","author":"Culnane","year":"1999","journal-title":"JAMA"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1542\/peds.2008-2771","article-title":". Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.","volume":"124","author":"Aldrovandi","year":"2009","journal-title":"Pediatrics"},{"key":"R25-12-20210202","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.mito.2004.07.025","article-title":"Mitochondrial dysfunction in AIDS and its treatment.","volume":"4","author":"Gerschenson","year":"2004","journal-title":"Mitochondrion"},{"key":"R26-12-20210202","first-page":"397","article-title":"Bray J, et al..","volume":"1","author":"Dagan","year":"2002","journal-title":"Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence Mitochondrion"},{"key":"R27-12-20210202","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/518976","article-title":"A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.","volume":"45","author":"Bolhaar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R28-12-20210202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01799112","article-title":". Clinical presentation of mitochondrial disorders in childhood.","volume":"19","author":"Munnich","year":"1996","journal-title":"J Inherit Metab Dis"},{"key":"R29-12-20210202","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1097\/CCM.0b013e3181a0f919","article-title":". Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study.","volume":"37","author":"Jansen","year":"2009","journal-title":"Crit Care Med"},{"key":"R30-12-20210202","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pediatrneurol.2007.12.001","article-title":"Presentation and diagnosis of mitochondrial disorders in children.","volume":"38","author":"Koenig","year":"2008","journal-title":"Pediatr Neurol"},{"key":"R31-12-20210202","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":". Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"R32-12-20210202","first-page":"5","article-title":"Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy Curr Opin Infect Dis.","volume":"13","author":"Brinkman","year":"2000","journal-title":""},{"issue":"suppl 1","key":"R33-12-20210202","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.qai.0000137004.63376.27","article-title":"Mitochondrial dysfunction: patient monitoring and toxicity management.","volume":"37","author":"McComsey","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-12-20210202","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1093\/hmg\/ddq246","article-title":". Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups.","volume":"19","author":"Gomez-Duran","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R35-12-20210202","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/hmg\/ddm101","article-title":". Genetic determinants of mitochondrial content.","volume":"16","author":"Curran","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R36-12-20210202","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1089\/aid.2010.0348","article-title":". Decrease in mitochondrial transmembrane potential in peripheral blood mononuclear cells of HIV-uninfected subjects undergoing HIV postexposure prophylaxis.","volume":"27","author":"Groener","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R37-12-20210202","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-145-11-200612050-00021","article-title":"Hyperlactatemia due to nevirapine.","volume":"145","author":"Panos","year":"2006","journal-title":"Ann Intern Med"},{"key":"R38-12-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/apc.2011.0068","article-title":"; for the Pediatric HIVAIDS Cohort Study. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.","volume":"25","author":"Griner","year":"2011","journal-title":"AIDS Patient Care and STDS"},{"key":"R39-12-20210202","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591706","article-title":". Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy.","volume":"47","author":"Nasi","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201112000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:48Z","timestamp":1786048188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201112000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318234c886","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}